Showing results (1711-1720 of 9,979) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|July 7, 2017
Alternative splicing of hTERT: a further mechanism for the control of active hTERT in acute myeloid leukemiaCeleste Calvello, Barbara Rocca, Catherine Klersy, et al.Leukemia & Lymphoma|July 7, 2017
Autoantibodies against β1-adrenergic receptor: response to induction therapy with bortezomib-containing regimens for multiple myeloma patientsWen Gao, Wen-Jia Guo, Dong-Yan Hou, et al.Leukemia & Lymphoma|May 10, 2018
MYC protein expression is an important prognostic factor in acute myeloid leukemiaMaro Ohanian, Uri Rozovski, Rashmi Kanagal-Shamanna, et al.Leukemia & Lymphoma|May 25, 2019
Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapyPrajwal Boddu, Preetesh Jain, Gautam Borthakur, et al.Leukemia & Lymphoma|May 10, 2019
Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registryOlga Salamero, David Martínez-Cuadrón, Marta Sobas, et al.Leukemia & Lymphoma|October 6, 2017
Comparison of chemoradiotherapy with radiotherapy alone for early-stage extranodal natural killer/T-cell lymphoma, nasal type in elderly patientsChang Su, Kevin A Nguyen, Harrison X Bai, et al.Leukemia & Lymphoma|November 8, 2019
Colonic mucosa-associated lymphoid tissue lymphoma: a case seriesJenny Tannoury, Aurélien Amiot, François Lemonnier, et al.Leukemia & Lymphoma|February 5, 2020
Interrogation of molecular profiles can help in differentiating between MDS and AML with MDS-related changesTalha Badar, Aniko Szabo, David Sallman, et al.Leukemia & Lymphoma|May 18, 2022
Factors associated with risk and prognosis of intensive care unit admission in patients with acute leukemia: a Danish nationwide cohort studyCecilie Velsoe Maeng, Christian Fynbo Christiansen, Kathleen Dori Liu, et al.Pageof 998